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knee defectsAseptic loosening and focal osteolysis are themost common reasons for knee arthroplasty failure. The best treatment
remains unclear.We reviewed the literature on the treatment of revision knee arthroplasty using bony structural al-
lografts (476 cases) and porousmetal cones (223 cases) to determine if a difference in the revision failure rates was
discernable. The failure rates were compared using a logistic regression model with adjustment for discrepancies in
FU time and number of grafts used (femoral, tibial, or both). In this analysis, the porous implant shows a signiﬁcantly
decreased loosening rate in AORI 2 and 3 defects. The overall failure rate was also substantially lower in the porous
metal group than the structural allograft group; little difference in the infection rates was noted.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Total knee arthroplasty (TKA) is now being recognized as one of the
most successful operations in orthopedic surgery for the treatment of
degenerative joint disease [1]. In the USA, because of the rapidly aging
population and the advent of improved surgical techniques with corre-
spondingly improved results, this procedure is being done with in-
creased frequency. According to Iorio et al. [2] a total of 523,000 TKAs
were performed in the USA in 2005, and this number is projected to in-
crease to 3,480,000 in 2030, representing amore thanﬁve-fold increase.
At the same time the number of revisions, which was 38,500 in 2005
(7.3%), is projected to increase to 268,200 in 2030. The most common
indication for knee arthroplasty revision is aseptic loosening in combi-
nation with periarticular osteopenia, focal osteolysis and infection [3].
Bony deﬁciencies are frequently encountered during TKA revision
surgery [3] and are classiﬁed according to the Anderson Orthopedic Re-
search Institute classiﬁcation (AORI). Various strategies have been de-
scribed to manage them [4], which predominantly depend on the size
of the bone defect. In addition to the use of long-stemmed prostheses,ying out this study.
ctly associated with this work.
rt outside the submitted work.
s article can be found at http://
rg University Hospital, Depart-
jury, Schlierbacher Landstraße
. This is an open access article underthese strategies often include the use of cement, metal augments, im-
paction bone grafting with morsellized bone, structural allografting
and the use of trabecular metal (TM) cones. For the management of
large bone defects (AORI grades 2 and 3) bulk or structural allografts
in combination with long-stemmed prostheses have been used for a
long time [5]. However, the use of these grafts is associatedwith a num-
ber of disadvantages including late graft resorption, fracture of the graft,
nonunion of the graft with the native bone and the risk of disease trans-
mission [6]. The improved osteointegration found with large porous
metal augments has resulted in improved outcomes and increased use
in hip arthroplasty surgery [7]. Therefore, with the increasing popularity
of large porous metal augments, it is likely that the use of structural al-
lografts for revision TKA will diminish in the future [3].
The purpose of this literature review is to determine if the use of TM
cones in patients with AORI 2 and 3 defects involving the knee joint im-
proves revision rates compared to the rates with the use of large struc-
tural allografts.
Material and Methods
Search Strategy
A search of Medline and Embase was conducted using deﬁned
search phrases and via citation tracking. The search included single
arm and controlled studies published between January 1980 andthe CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Structural (Bulk) Allograft of Knees.
First Author Year Age Years (Mean) Total Knees # Grafts
F/U Months Reoperation Due to
Mean (Range) Aseptic Loosening or Fracture of Allograft Infection Non-Allograft Related
Chun [15] 2013 68 27 38 107 (96–157) 0 1 0
Wang [36] 2013 69.7 30 38 76 (38–136) 0 0 0
Burnett [37] 2009 67.3 28 33 48 (24–96) 1 1 0
Lyall [38] 2009 59 15 15 65 (33–115) 1 1 0
Bauman [39] 2009 67.9 70 87 90 (60–178) 8 5 3
Engh [9] 2007 67 46 46 97 0 2 2
Bezwada [40] 2006 64 11 11 42 (36–48) 0 0 0
Backstein [41] 2006 73.4 61 68 65 (12–192) 6 4 3
Clatworthy [42] 2001 66 52 66 97.2 97.2 5 4 4
Engh [16] 1997 70 30 33 50 (24–120) 0 0 1
Ghazavi [13] 1997 65.8 30 34 50 (24–132) 4 3 0
Mow [14] 1996 63 13 15 47 (30–101) 1 0 3
Harris [10] 1995 67 14 14 43 (29–63) 0 1 0
Tsahakis [12] 1994 72 15 19 25 (12–48) 0 0 0
Stockley [11] 1992 69.4 12 12 50 (24–86) 2 3 0
Mnaymeh [20] 1990 67 10 10 40 (26–69) 2 1 0
Wilde [21] 1990 62 12 12 30 (25–51) 1 0 0
TOTAL 67.9 476 551 70.8 31 26 16
% 6.51% 5.46% 3.36%
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cones and structural allograft. The medical subject headings were
“structural allograft and/or femoral head allograft in the revision of
total knee arthroplasties” and “Trabecular Metal augments in revision
total knee arthroplasty”.
Studieswere included if the bone loss at the timeof revisionwas clas-
siﬁed as AORI grade 2 or 3 and either large bulk or structural allografts or
TM cones were utilized during the revisions. A description of bone loss
judged to be severe enough to fall into the AORI grade 2 or 3was utilized
for studies published prior to the widely spread adoption of the AORI
classiﬁcation. In addition, patients had to have clinical and radiographic
follow up. Single case reports and review articles were excluded. Data
extraction included names of authors, study type, year of publication,
type of revision surgery, mean duration of follow up and revision rate.
AORI grade 2 defects involve loss of cancellous bone in one (2A) or
both (2B) metaphyses and condyles. These defects require restoration
of the joint line and are best managed with a revision component that
consists of augments and a stem [8]. AORI grade 3defects consist of larger
metaphyseal defectswith bone damage to or above the femoral condyles
or up to or below the tibial tubercle requiring large structural grafts and
long-stemmed revision implants [8]. In the publications on large struc-
tural allografts, the prostheses were cemented to the host bone with
the exception of one series [9] and frequently the allograft was cemented
to the prosthesis as well [10–16]. In the series utilizing TM cones, only
Panni et al [17] did not specify if bone cementwas used. In all other series
utilizing TM cones, bone cement was used between the prosthesis and
host bone and between the prosthesis and TM cone. Bone cement was
never used between bone graft or the TM cone and the host bone.
The radiographic criteria for loosening included the breaking of the
screws ﬁxing the allograft to the native bone, a radiographic lucency
around the allograft or prosthesis of 2mmormore, especially if increas-
ing over time, andmovement of the allograft or prosthesis on follow up
radiographs. Failure rates described in Tables 1 and 2 reﬂect the cases
requiring surgical revision. In general, revision was performed based
upon clinical symptoms (i.e., pain) and not the result of the radiological
ﬁndings described above.
Statistics
Primary outcome was a binary, patient-level variable, namely suc-
cess or failure (i.e., aseptic loosening) within the study-speciﬁc follow-
up period. Logistic regression was used to estimate the failure odds
ratio and its 95% conﬁdence interval (CI) for the two revision techniques
using TM cones and large allografts. Heterogeneity of the studies wasaccounted for bymeans of the robust Huber–White sandwich estimator
for the covariance matrix and standard errors of the parameter esti-
mates. The analysis was adjusted for different length of the follow-up
period by using the logarithm of the study-speciﬁc average follow-up
time as an offset variable in the model (see Appendix 4 in Ref. [18]).
The follow-up time was further adjusted for those cases, which had
received grafts to both femoral and tibial defects, since both the fem-
oral and tibial graft could fail. This adjustment assumes a time-
homogeneous failure rate in both treatments, which we argue is a
conservative adjustment in the present context. Average failure
rates, along with their 95% conﬁdence intervals, were determined
from the baseline odds of intercept-only logistic regression models.
The secondary outcome, namely, infections and overall revision
rates, were analyzed in the same way as the primary outcome.
Results
After excluding duplicates we found a total of 102 articles and ab-
stracts. Twenty-seven of these publications dealt with TM cones in
knee revision surgery. Seventeen of these papers were review articles
and experimental studies. Ten papers fulﬁlled the inclusion criteria
with the ﬁrst clinical series appearing in 2006 [19]. The literature search
on large structural allografts in knee revision surgery yielded 75 publi-
cations. Of these, 17 fulﬁlled the inclusion criteria with the ﬁrst clinical
series appearing in 1990 [20,21].
The included articles consist entirely of case series describing the use
of TM cones and large bulk allografts in patients with severe bone de-
fects found during knee revision surgery: controlled trials or even ran-
domized controlled trials were not available.
There were a total of 10 articles published between 2006 and 2013
(Table 2) that reported on the outcome of 254 TM cones in 223 revision
TKAs. Thirty-one of the TKAs involved both tibial and femoral implants,
in 75 TKAs cones were placed only in femurs and in 117 TKAs only in
tibias. We deﬁned failures as those cases that required reoperation.
The average age of these patients at the time of revision surgery was
69.5 years and they had a mean follow up of 33.6 months (2.8 years).
The loosening rate of the TM cones was 0.9% (all femoral) and the loos-
ening rate of the prosthesis and/or incidence of periprosthetic fracture
was also 0.9%. The infection rate necessitating surgical intervention
was 2.2%.
Bulk allographs (Table 1) have been used for amuch longer period of
time and therefore longer follow-up periods are available. There were a
total of 551 bulk allografts used in 476 revision TKAs described in 17 ar-
ticles. In 75 of these revision TKAs, bulk allografts were placed in both
Table 2
Trabecular Metal Cones.
First Author Year Age Years (Mean) Knees With Cones # Cones
F/U Months Reoperation Due to
Mean (Range) Aseptic Loosening of Cone Infection Loose Prosthesis/Fracture
Rao [43] 2013 72 26 29 36 (24–49) 0 0 0
Villanueva-Martinez [44] 2013 73.3 21 29 36 0 1 0
Derome [45] 2013 70 29 33 33 (13–73) 0 0 0
Schmitz [46] 2013 72 38 54 37 (32–48) 1 0 1
Panni [17] 2013 75 9 9 84 0 0 0
Lachiewicz [47] 2012 64.6 33 33 40 (24–68) 1 1 1
Howard [48] 2011 64 24 24 33 0 0 0
Meneghini [49] 2009 68.1 15 15 34 n/a 0 0
Long [50] 2009 66.1 16 16 31 n/a 2 0
Radnay [19] 2006 – 12 12 10.2 0 1 0
TOTAL 69.5 223 254 33.6 2 5 2
% 0.9% 2.2% 0.9%
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132 only in the femur. In 74 TKAs the location of the bulk allograft was
not speciﬁed. The mean follow-up period was 70.8 months (5.9 years).
The average age of these patients at the time of revision surgery was
67.9 years. In these patients the failure rate of the allograft requiring re-
operation from either loosening or fracture of the graft was 6.5%; the re-
operation due to loosening of the prosthesis was 3.4 % and due to
infection was 5.5%.
The differences in follow-up times also result in differences in inci-
dents (failures), requiring a logistic metaregression to compensate for
the difference using offset variables. In the 10 TM and 17 allograft arti-
cles, 805 grafts (TM cones and bulk allografts) were evaluated. Thirty-
three aseptic graft loosenings were noted: 2 occurred in the TM and
31 in the allograft group, corresponding to a yearly failure rate of 0.3%
(CI 0.1 to 0.7%) and 1.0% (CI 0.6 to 1.6%) in the twomaterials. Assuming
time-homogeneous failure rates, metaregression reveals an odds ratio
for aseptic loosening of 0.263 (CI 0.085 to 0.816, P= 0.021) in favor of
TM (see Fig. 1 Forest plot).
Of the 805 grafts evaluated, 31 became infected: there were 5 in the
TM group and 26 in the allograft group (yearly failure rate: TM, 0.7%, CI
0.2 to 1.8%; allograft, 0.8%, CI 0.6 to 1.2%). Correspondingly,
metaregression analysis did not reveal a substantial difference between
the TM and allograft collectives. The odds ratio for infection using an as-
sumed time-homogeneous failure rate was 0.804, slightly in favor of
TM, but far from statistically signiﬁcant (CI 0.273 to 2.364, P= 0.692).
When evaluating the overall revision rate of both collectives, again,
no signiﬁcant difference was found. A total of 82 of 805 grafts were sur-
gically revised, with an odds ratio of 0.473 (CI 0.212 to 1.055, P=0.067)
and yearly re-revision rates of 1.2% (CI 0.6 to 2.5%) for TM and 2.6% (CI
1.7 to 2.8%) for allografts, respectively. Although the overall re-
revision rate is not statistically signiﬁcant, a tendency toward a de-
creased rate from all causes is noted for TM cones.
Discussion
TMcomponents are believed to have increased biocompatibility [22]
and enhanced bone ingrowth andﬁxation [23]. In a previous publication
on revision total hip arthroplasty comparing TMaugmentswith revision
rings, we showed a signiﬁcantly decreased loosening rate of TM compo-
nents [7]. We therefore conducted a metaregression analysis of the
available literature on revision TKA with TM components or structural
allografts utilizing the criteria outlined above, and compared the rate
of failure due to lack of ﬁxation of the TM graft and bulk allograft to
the host bone as well as the infection and overall revision rates.
Bone allografts are frequently required in orthopedic surgery. They
are usually procured sterile from organ donors and stored at−80 °C.
Consequently, these grafts have limited biological activity [24]. Al-
thoughmorsellized cancellous allografts have been shown to slowly re-
model into viable bone [24] and have been shown to be highlysuccessful for smaller defects, larger structural allografts are frequently
required for large defects in knee revision surgery, where they need to
provide structural support [25]. Ideally, the allograft should be attached
to the host bone by the stem of the prosthesis alone [26,27], but addi-
tional ﬁxation with plate and screws may be necessary. In dog experi-
ments, Stevenson et al. [28] found that bony union is dependent on
the type of graft and the immune response of the host. They found
only very limited revascularization and remodeling and a very unpre-
dictable incorporation process. Parks et al. [29] examined human bone
allografts histologically; these had been retrieved during revision sur-
gery or at autopsy 41 months (range 20–62 months) postoperatively.
They found that some new bone was laid down only on the periphery
of the structural allograft and that these large allografts showed no re-
modeling and no revascularization when they were examined. Pub-
lished complications include resorption of the graft [30], a fracture
rate of 16% [31] and a late infection rate of 11.7% [32]. The incidence of
nonunion of large frozen allografts with the host bone was 11% [33] al-
though this did not appear to affect the chance of retention of the graft.
Since large allografts have signiﬁcant disadvantages, porous metal
implants have been introduced by several orthopedic supply compa-
nies. The advantage of these newer materials is thought to be the in-
creased porosity, the low modulus of elasticity and high coefﬁcient of
friction [22]. These materials allow for enhanced and accelerated bone
ingrowth [34] when compared to older implants with roughened sur-
faces. In experimental studies, Bobyn et al. [23] found 13% ﬁlling in of
the tantalum pores with bone after 2–3 weeks and 63–80% bony ﬁlling
in of the tantalum pores after 16–52 weeks. The highly porous charac-
teristics of these new porous metal compounds are claimed to further
increase rapid and early osteointegration [22,34] and should therefore
diminish the loosening rate and improve clinical results and long term
outcomes. If failures occur, they tend to happen early on in the postop-
erative period according to Jafari et al. [35]; in their group of 79 patients
who had undergone total hip revision surgery with TM augments, 4 out
of 5 failures occurred in the ﬁrst 6 months postoperatively. However,
the advantages of these porous implants are negated if they are
cemented to viable bone. Because of the increased osteointegration of
these materials, their removal in case of revision surgery for any reason
can be difﬁcult.
In our literature search we compared the overall results of TM
cones in knee revision surgery with those results using large allo-
grafts (Tables 1 and 2) by using a metaregression analysis. When
using TM cones we have seen a statistically signiﬁcant odds ratio
for aseptic loosening of only about ¼ of that seen with structural
or bulk allograft. This leaves much room for speculation as to the
reason; however, the biological response to the foreign graft is
the most likely reason for the discrepancy. As mentioned,
osteointegration of a porous metal graft improves secondary sta-
bility, whereby bony resorption and restructuring of the allograft
can result in graft failure.
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Fig. 1. Forest plot displaying study-speciﬁc failure rates per person and year for the two materials.
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2 groups. The odds ratio of 0.804 in favor of TMwas not signiﬁcant (P=
0.692) and the large P-value probably indicates that even a substantially
larger collective would not reveal a signiﬁcant difference between the
two groups. Operations in both groups involve implantation of a foreign
material, with limited biological potential, which could account for the
similarity of the infection rates.
Statistical analysis of the overall revision rates does, however, indi-
cate a tendency toward decreased revision rates in the trabecular
metal population (odds ratio = 0.473, P= 0.067), or roughly half that
seen in the allograft group. The limited population size did not allow
for a discernable effect on the conventional statistical signiﬁcance level.
The major drawback of our comparison study is the absence of any
randomized controlled trial in the literature, so that all results have to
be considered preliminary, stating whether TM might be a promising
treatment option or not. An unequivocal recommendation for a speciﬁc
treatment is not possible on the basis of the current evidence. The re-
sults of the present literature review should therefore not be considered
as decisive but rather as hypothesis generating regarding future, pro-
spective, randomized controlled studies.
Since our analyses are conﬁned to case series, a further problem is
the difference in the length of the follow up period of the TM cone
group compared to the bulk allograft group. In the statistical compari-
son we adjusted for these different follow up periods by entering the
logarithm of the follow up period as an offset [18]. The offset also
accounted for the number of prostheses implanted (femoral, tibial, or
both). Such an analysis assumes that the failure rate is constant over
time and the same in the two sites (it was not possible to determine
separate failure rates for femoral and tibial revisions because not all
studies separately reported these numbers). Both assumptions may be
incorrect: TM related studies are anticipated to have better long-term
outcomes than the average of the yearly failure rate suggests. Both ex-
perimental studies [23] and clinical studies [35] show improved early
osteointegration with TM components and therefore a decreased loos-
ening rate can be expected later on. If we assume that with TMcomponents the majority of mechanical complications happen early
postoperatively as suggested by Jafari et al. [35], our results clearly
favor the use of TM components in knee revision surgery over bulk allo-
grafts. In addition, the use and implantation of porousmetal is constant-
ly evolving, with some companies providing their own broaching
systems to allow for improved press-ﬁt implantation. The increased
use of porous metals and the increased familiarity with the technique
of its implantation may further improve the outcome of surgical proce-
dures using these materials.
Our review of the literature supports the results and conclusions
drawn by experimental studies involving large bone allografts
[24,28,29] and TM components [22,23,34] showing that the improved
biocompatibility and osteointegration of porous implants might result
in a substantially lower loosening rate. The limited number of cases
did not indicate that the infection rate or overall revision rates varied.
These ﬁndings are similar to clinical results we found in revision hip
arthroplasty [7]. However, for further validation, a longer follow up pe-
riod in these patients who undergo knee revision surgerywith TM com-
ponents is still required. Because of the observational nature of the
included studies, the meta-regression results should not be considered
conclusive but rather strongly indicative of improved results with the
use of TM cones.
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